DURRENBERGER FRAN,BUHR WILM,CORDEN VINCENT ANTHONY,DAVENPORT TARA,SLACK MARK,YAU WEI TSUNG,BURCKHARDT SUSANNA,FUNK FELIX,COURTNEY STEPHEN MARTIN,JAEGER STEFAN,YARNOLD CHRISTOPHER JOHN,GEISSER PETER OT
申请号:
TN2012000045
公开号:
TN2012000045A1
申请日:
2012.01.27
申请国别(地区):
TN
年份:
2013
代理人:
摘要:
The present invention relates to novel hepcidine antagonists of the formula (I), comprising pharmaceutical compositions and the use thereof as medications, in particular for treating iron metabolism disorders, such as in particular iron deficiency diseases and anemias, in particular anemias in conjunction with chronic inflammatory diseases (ACD, anemia of chronic disease, and AI, anemia of inflammation).